Maxim Schillebeeckx

Senior Director, Business Development & Licensing at Eikon Therapeutics

Maxim Schillebeeckx is a highly accomplished individual with a background in business development, licensing, and alliance management in the biopharma and healthcare industries. With a strong foundation in molecular genetics and genomics, Maxim has held key roles in companies such as Eikon Therapeutics, The BALSA Foundation, Guardant Health, and BioReference Laboratories. Maxim's expertise lies in identifying, evaluating, and leading due diligence for technology platforms in oncology, establishing research collaborations, and driving commercial growth for genomic medicine platforms. With a Ph.D. in Molecular Genetics and Genomics, Maxim brings a unique blend of scientific knowledge and business acumen to the organizations Maxim works with.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Eikon Therapeutics

3 followers

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.


Employees

51-200

Links